Effects of hormonal contraception on bone mineral density after 24 months of use

被引:72
作者
Berenson, AB
Breitkopf, CR
Grady, JJ
Rickert, VI
Thomas, A
机构
[1] Univ Texas, Dept Obstet & Gynecol, Med Branch, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77550 USA
[3] Wilford Hall USAF Med Ctr, San Antonio, TX 78236 USA
关键词
D O I
10.1097/01.AOG.0000117082.49490.d5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To measure the effect of 24 months of depot medroxyprogesterone acetate use on bone mineral density compared with oral contraception (pills) and nonhormonal contraception. METHODS: Women aged 18-33 years self-selected oral contraception, depot medroxyprogesterone acetate, or nonhormonal contraception (controls). Those selecting pills were randomized to formulations containing either 35 mug ethinyl estradiol and norethindrone or 30 mug ethinyl estradiol and desogestrel. Controls were frequency matched on age and race/ethnicity to hormonal contraception users. Dual-energy X-ray absorptiometry of the lumbar spine (L1-L4) was performed at baseline, 12 months, and 24 months. Percent change in bone mineral density was analyzed by using analysis of covariance, adjusting for age, race/ethnicity, weight-bearing exercise, calcium intake, smoking status, and body mass index. RESULTS: Of the 191 women making up the final sample, 86 used pills, 47 used depot medroxyprogesterone acetate, and 58 used nonhormonal contraception. Women using depot medroxyprogesterone acetate for 24 months experienced, on average, a 5.7% loss in bone mineral density, with a 3.2% loss occurring between months 12 and 24. On average, users of desogestrel pills experienced a 2.6% loss in bone mineral density after 24 months. Bonferroni-adjusted pairwise comparisons demonstrated that bone mineral density changes from baseline to 24 months among depot medroxyprogesterone acetate users differed significantly from changes experienced by either of the pill groups or the control group. Changes in bone mineral density among users of either pill did not significantly differ from each other or from controls. CONCLUSION: Loss of bone mineral density associated with depot medroxyprogesterone acetate use appears to be linear during the first 2 years of use. Shifts in bone mineral density among pill users were not significant when compared with controls. ( (C) 2004 by The American College of Obstetricians and Gynecologists.).
引用
收藏
页码:899 / 906
页数:8
相关论文
共 30 条
  • [1] [Anonymous], DIET RREF INT CALC P
  • [2] A prospective, controlled study of the effects of hormonal contraception on bone mineral density
    Berenson, AB
    Radecki, CM
    Grady, JJ
    Rickert, VI
    Thomas, A
    [J]. OBSTETRICS AND GYNECOLOGY, 2001, 98 (04) : 576 - 582
  • [3] Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years
    Busen, NH
    Britt, RB
    Rianon, N
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2003, 32 (04) : 257 - 259
  • [4] A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives
    Cromer, BA
    Blair, JM
    Mahan, JD
    Zibners, L
    Naumovski, Z
    [J]. JOURNAL OF PEDIATRICS, 1996, 129 (05) : 671 - 676
  • [5] RECOVERY OF BONE-DENSITY IN WOMEN WHO STOP USING MEDROXYPROGESTERONE ACETATE
    CUNDY, T
    CORNISH, J
    EVANS, MC
    ROBERTS, H
    REID, IR
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6923) : 247 - 248
  • [6] Spinal bone density in women using depot medroxyprogesterone contraception
    Cundy, T
    Cornish, J
    Roberts, H
    Elder, H
    Reid, IR
    [J]. OBSTETRICS AND GYNECOLOGY, 1998, 92 (04) : 569 - 573
  • [7] A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate
    Cundy, T
    Ames, R
    Horne, A
    Clearwater, J
    Roberts, H
    Gamble, G
    Reid, IR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) : 78 - 81
  • [8] Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception
    Cundy, T
    Cornish, J
    Roberts, H
    Reid, IR
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (05) : 978 - 983
  • [9] BONE-DENSITY IN WOMEN RECEIVING DEPOT MEDROXYPROGESTERONE ACETATE FOR CONTRACEPTION
    CUNDY, T
    EVANS, M
    ROBERTS, H
    WATTIE, D
    AMES, R
    REID, IR
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6793) : 13 - 16
  • [10] The influence of body size, smoking, and diet on bone density in pre- and postmenopausal women
    Franceschi, S
    Schinella, D
    Bidoli, E
    DalMaso, L
    LaVecchia, C
    Parazzini, F
    Zecchin, R
    [J]. EPIDEMIOLOGY, 1996, 7 (04) : 411 - 414